CLINICAL_TRIALS
trial_result
· 2022-11-09
Clinical Trial Update: RAD001 for Non-clear Cell Renal Cell Carcinoma (RCC) [Phase 2]
Summary
Phase 2 clinical trial update for RAD001 in non-clear cell renal cell carcinoma has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Seoul National University Hospital | Conditions: Renal Cell Carcinoma | Phase 2 | Status: COMPLETED